Abacavir Lamivudine 300mg and 600mg tablets Online

The recommended dosage of Abacavir Lamivudine in adults is one tablet taken orally once daily, combined with other antiretroviral agents, with or without food.

The recommended oral dose of Abacavir Lamivudine for pediatric patients weighing at least 25 kg is one tablet daily in combination with other antiretroviral agents. 

The common side-effects of Abacavir Lamivudine are insomnia, drug hypersensitivity, depression or depressed mood, nausea, headache or migraine, fatigue or malaise, dizziness or vertigo, and diarrhea.

• Healthcare professionals should screen all the patients for the HLA-B*5701 allele before initiating therapy with Abacavir Lamivudine or reinitiating therapy with this combination medicine unless patients have a previously documented HLA-B*5701 allele assessment. 
• Abacavir Lamivudine is contraindicated in patients with a prior hypersensitivity to abacavir and HLA-B*5701-positive patients.
•  Before starting Abacavir Lamivudine, one should review medical history for prior exposure to any abacavir-containing product. One should never restart the combination medicine or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status. 
• To reduce the risk of a life-threatening hypersensitivity reaction, regardless of HLA-B*5701 status, one should discontinue the medicine immediately if a hypersensitivity reaction is suspected, even when other diagnoses are possible (e.g., acute onset respiratory diseases such as pneumonia, bronchitis, pharyngitis, or influenza; gastroenteritis; or reactions to other medications).
•  If a hypersensitivity reaction cannot be ruled out, do not restart the combination medicine or other abacavir-containing products because more severe symptoms, including life-threatening hypotension and death, can occur within hours. 
• If a hypersensitivity reaction is ruled out, patients may restart Abacavir Lamivudine. Rarely have patients who have stopped abacavir for reasons other than symptoms of hypersensitivity also experienced life-threatening reactions within hours of reinitiating abacavir therapy. Therefore, reintroducing the medicine or any other abacavir-containing product is recommended if medical care can be readily accessed.

Is Abacavir Lamivudine approved by the FDA?

The FDA approved this combination medicine Abacavir Lamivudine in 2004 for patients who have HIV-1 infection. 

What class of drug is Abacavir & Lamivudine?

The drugs Abacavir and Lamivudine belong to nucleoside analogue HIV-1 reverse transcriptase inhibitors. 

How to store the combination medicine Abacavir and Lamivudine?

One should store this combination of medicine at 59°F to 86°F (15°C to 30°C). 

What should one do if someone takes an overdose of Abacavir Lamivudine?

There is no known specific treatment for an overdose with Abacavir Lamivudine. If a patient takes an overdose, the patient should be monitored, and standard supportive treatment applied as required. 

Is the combination drug Abacavir Lamivudine available in India?

The combination medicine Abacavir Lamivudine is a (prescription drug, doctor-prescribed medication, or health care professional-prescribed medicine) pharmaceutical drug that can be legally dispensed against a medical prescription.

Abacavir Lamivudine tablets can be made available through the network of authorized distributors in India. (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)

Can You Send the Combination medicine Abacavir Lamivudine to Foreign Destination?

Buy generic Abacavir Lamivudine combination medicine online at the best/lowest price in India from a leading supplier. Indian Generic Medicines can assist in the delivery of this medicine; the doctor prescribed medication to the USA, UK, Canada, Australia, China, Saudi Arabia, Thailand, South Africa, Zambia, Pakistan, Qatar, Kuwait, Sweden, Hong kong, UAE, Philippines, Kazakhstan, Turkey, Singapore, Malaysia, Sri Lanka, Uzbekistan Afghanistan, Nepal, Japan, and many more countries.